NCT07514247

Brief Summary

Peripheral intravenous catheters (PIVCs) are widely used invasive devices in hospital settings and are associated with a broad range of complications, among which infiltration is one of the most common and clinically significant. Infiltration, defined as the leakage of intravenous fluids or medications into surrounding tissues, may result in local tissue damage, pain, infection, delayed treatment, and increased healthcare costs. Despite its high prevalence and impact on patient safety, early recognition and appropriate management of infiltration remain challenging, particularly among nursing students. Conventional educational approaches that rely predominantly on theoretical instruction may be insufficient to develop the clinical reasoning and decision-making skills required for timely identification and management of such complications. Therefore, there is a growing emphasis on the use of innovative, learner-centered educational strategies that promote active participation and experiential learning. Simulation-based education, including in situ simulation and standardized patient methodologies, has been shown to provide realistic, safe, and effective learning environments that enhance both technical and non-technical skills. In situ simulation enables training within real clinical settings using existing resources and team structures, while standardized patients facilitate the development of communication, clinical assessment, and decision-making competencies. This randomized controlled trial aims to evaluate the effectiveness of standardized patient and in situ simulation-based training, compared with traditional teaching methods, in improving nursing students' ability to recognize PIVC-related infiltration and enhance their clinical decision-making skills. Secondary outcomes include learning satisfaction and self-confidence. By integrating evidence-based simulation approaches into nursing education, this study seeks to strengthen clinical competence and contribute to improved patient safety outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Apr 2026May 2026

First Submitted

Initial submission to the registry

March 26, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 7, 2026

Completed
18 days until next milestone

Study Start

First participant enrolled

April 25, 2026

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2026

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2026

Expected
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

10 days

First QC Date

March 26, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

in-situ simulationnursing educationsimulation based learningpatient safetyinfiltration

Outcome Measures

Primary Outcomes (2)

  • Infiltration Knowledge Test

    The "Infiltration Knowledge Test" will be administered to students in both the experimental and control groups before the intervention and after skill performance assessments. The knowledge test consists of 10 multiple-choice questions prepared by the researcher based on the literature. Scores on the test range from 0 to 100. Scores closer to 100 can be interpreted as an increase in students' knowledge of infiltration.

    Pre-intervention and immediately after the intervention

  • Clinical Decision-Making Skills

    Clinical decision-making perception has been assessed using Jenkins' (1983) clinical decision-making performance scale. The original Clinical Decision-Making Performance Scale consists of 40 items and four sub-dimensions. A reliability and validity study of clinical decision-making performance in Turkish clinics was conducted by Durmaz and Dicle (2015). The subscales are, respectively: "Exploring options and comprehensively", "Investigating goals and values", "Evaluating outcomes", and "Researching information and following up as new records". The total score of the scale is between 40 and 200, and the sub-dimension score is between 10 and 50; there is no cutoff point. A high score indicates a high perception of decision-making, while a low score indicates a low perception of decision-making. The scale is evaluated based on its subscale and total scale score.

    Pre-intervention and immediately after the intervention

Secondary Outcomes (2)

  • Student Satisfaction and Self-Confidence Scale in Learning

    immediately after the intervention

  • Simulation Design Scale

    Immediately after the intervention

Study Arms (3)

Arm 1: Standardized Patient Simulation Group

EXPERIMENTAL

Description: Participants receive training through standardized patient-based simulation scenarios specifically designed to represent early and progressive signs of PIVC-related infiltration. Students perform patient assessment, clinical reasoning, and decision-making tasks in a controlled environment. Each session includes structured debriefing using an evidence-based model (e.g., PEARLS).

Other: Intervention: Standardized Patient Simulation

Arm 2: In Situ Simulation Group

EXPERIMENTAL

Description: Participants engage in simulation conducted in real clinical settings using existing hospital equipment and workflows. Scenarios focus on the recognition and management of infiltration within authentic clinical contexts. The intervention emphasizes situational awareness, teamwork, and system-based factors. Structured debriefing is conducted following each session.

Other: Intervention: In Situ Simulation

Arm 3: Control Group (Traditional Education)

NO INTERVENTION

Arm 3: Control Group (Traditional Education) Intervention: Traditional Teaching Description: Participants receive conventional education consisting of theoretical instruction (e.g., lectures and/or standard skills demonstrations) related to PIVC complications, including infiltration, without exposure to simulation-based training.

Interventions

Description: Participants receive training through standardized patient-based simulation scenarios specifically designed to represent early and progressive signs of PIVC-related infiltration. Students perform patient assessment, clinical reasoning, and decision-making tasks in a controlled environment. Each session includes structured debriefing using an evidence-based model (e.g., PEARLS).

Arm 1: Standardized Patient Simulation Group

Description: Participants engage in simulation conducted in real clinical settings using existing hospital equipment and workflows. Scenarios focus on the recognition and management of infiltration within authentic clinical contexts. The intervention emphasizes situational awareness, teamwork, and system-based factors. Structured debriefing is conducted following each session.

Arm 2: In Situ Simulation Group

Eligibility Criteria

Age18 Years - 23 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • First-year undergraduate nursing students at the Faculty of Nursing
  • Students enrolling in the "Fundamentals of Nursing" course for the first time
  • Students who gave informed consent and agreed to participate in the study voluntarily.

You may not qualify if:

  • Students reviewing the "Fundamentals of Nursing" course
  • Students who refused to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Central Study Contacts

Selçuk Görücü, PhD student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This study is a randomized controlled trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD Student and Lecturer

Study Record Dates

First Submitted

March 26, 2026

First Posted

April 7, 2026

Study Start

April 25, 2026

Primary Completion

May 5, 2026

Study Completion (Estimated)

May 25, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share